<DOC>
	<DOCNO>NCT01815099</DOCNO>
	<brief_summary>We investigate feasibility efficacy transcranial magnetic stimulation ( TMS ) patient GAD placebo nonresponders DIEF003523.1 .</brief_summary>
	<brief_title>Transcranial Magnetic Stimulation Treatment Generalized Anxiety Disorder</brief_title>
	<detailed_description>We expect enroll five patient GAD fail respond sham ( placebo ) TMS intervention . In pilot study enrol three participant protocol include 10 rTMS session ( twice week five week ) one protocol include 15 rTMS session ( three time week five week ) . Assessments occur pretreatment posttreatment .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<criteria>Participated study DIEF003523.1 , receive sham `` placebo '' TMS achieve &lt; 50 % improvement HARS 3 month followup . Fluency English Capacity understand nature study willingness sign inform consent form History epilepsy head trauma ( LOC &gt; 5 minute ) within past 6 month Lifetime history increase intracranial pressure , seizure disorder , stroke , brain tumor , multiple sclerosis , brain surgery A review patient medication study physician indicates increase risk seizure An active autoimmune , endocrine , viral , vascular disorder affect brain ; unstable cardiac disease ; hypertension ; severe renal liver insufficiency Substance use disorder PTSD within past 6 month Lifetime bipolar disorder , obsessivecompulsive disorder ( OCD ) , psychotic disorder , mental retardation , pervasive developmental disorder Any psychotic feature , include dementia delirium Concurrent psychotherapy unwillingness discontinue Medication change within past 4 week Current serious suicidal homicidal ideation , and/or serious suicidal attempt within past 6 month Serious , unstable , terminal medical condition clinically judge psychiatrically unstable participate study Any contraindication participation MRI scan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>